EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety
Trial details
- Registry ID
- NCT07523581
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and SafetyNCT07523581 | ELOX | Phase 2 | Recruiting | 2027-06-30Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |